In the last trading session, 1.51 million Windtree Therapeutics Inc (NASDAQ:WINT) shares changed hands as the company’s beta touched 0.53. With the company’s per share price at $0.13 changed hands at $0.0 or -3.83% during last session, the market valuation stood at $1.38M. WINT’s last price was a discount, traded about -11246.15% off its 52-week high of $14.75. When we look at Windtree Therapeutics Inc’s average trading volume, we note the 10-day average is 8.89 million shares, with the 3-month average coming to 3.23 million.
Analysts gave the Windtree Therapeutics Inc (WINT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WINT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Windtree Therapeutics Inc’s EPS for the current quarter is expected to be -0.92.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Instantly WINT was in red as seen at the end of in last trading. With action -20.66%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -64.04%, with the 5-day performance at -20.66% in the red. However, in the 30-day time frame, Windtree Therapeutics Inc (NASDAQ:WINT) is -64.04% down. Looking at the short shares, we see there were 30861.0 shares sold at short interest cover period of 0.01 days.
Windtree Therapeutics Inc (WINT) estimates and forecasts
Data shows that the Windtree Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -98.75% over the past 6 months, a 93.99% in annual growth rate that is considerably higher than the industry average of 15.90%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 66.05%. The 2025 estimates are for Windtree Therapeutics Inc earnings to increase by 94.00%.
WINT Dividends
Windtree Therapeutics Inc is expected to release its next quarterly earnings report in March.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.27% of Windtree Therapeutics Inc shares while 2.06% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.07%.
Among Mutual Funds, the top two as of Nov 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . With 3.32 shares estimated at $416.0 under it, the former controlled 0.03% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.02% of the shares, roughly 2.31 shares worth around $290.0.
